Please login to your online account to display your discounted pricing

Sino Biological™ IL17RA Recombinant Human Protein, hIgG1-Fc.His Tag DFS Item

This recombinant protein was expressed from a DNA sequence encoding the extracellular domain (Met 1-Trp 320) of human IL17RA (NP_055154.3) fused to the polyhistidine-taggged Fc region of human IgG1 at the C-terminus

$90.56 - $768.60

Specifications

Purity ≥85% by SDS-PAGE
Endotoxin Concentration <1 EU/μg
Format Lyophilized
Gene Alias CD217, CDw217, IL-17RA, IL17R, mgC10262, hIL-17R, IL17RA
Gene ID (Entrez) 23765
View More Specs

 Disclaimers

For Research Use Only. Not for use in diagnostic procedures.

Products
Catalog Number Mfr. No. Quantity Price Quantity    

10895H03H25

DFS Item
 
life technologies
LS10895H03H25
5 x 5μg Each for $226.80

10895H03H5

DFS Item
 
life technologies
LS10895H03H5
5μg Each for $90.56

10895H03H50

DFS Item
 
life technologies
LS10895H03H50
50μg Each for $294.00

10895H03HL

DFS Item
 
life technologies
LS10895H03H250
5 x 50μg Each for $768.60
Description & Specifications

Specifications

Purity ≥85% by SDS-PAGE
Endotoxin Concentration <1 EU/μg
Format Lyophilized
Gene Alias CD217, CDw217, IL-17RA, IL17R, mgC10262, hIL-17R, IL17RA
Gene ID (Entrez) 23765

Interleukin 17 Receptor A (IL17RA), recombinant human protein is supplied as a lyophilized powder. In general, recombinant proteins are suitable for use in studying protein-protein interactions, as a protein standard, or in cell biology research applications.

  • Activity: 1. Measured by its ability to bind human IL17F in a functional ELISA; 2. Immobilized recombinant human IL17A at 20μg/mL (100μL/well) can bind human IL17RA with a linear range of 32-160ng/mL
  • Formulation: Lyophilized in PBS, pH 7.4, 5% Mannitol, 5% Trehalose, and 0.02% Tween 80
  • Reconstitution: Dissolve the protein in sterile double distilled water to a concentration of 0.2mg/mL or lower; aliquot and use as soon as possible

Shipping Condition: Room Temperature. This protein is manufactured by Sino Biological Inc.